Orchid Chem receives EU approval for bacterial injection

News Flash

Email us at buyorsell@ndtv.com
Call us at 011-26201171
CALL US AT 011-26201171
EMAIL US AT BUYORSELL@NDTV.COM
CALL US AT 011-26201171
EMAIL US AT BUYORSELL@NDTV.COM
OPEN MARKET OPERATIONS OF RBI ARE A PART OF REGULAR LIQUIDITY MANAGEMENT
STEEL MINISTRY FORMS COMMITTEE TO RESTRUCTURE PSU'S LIKE MSTC, KIOCL
STEEL MINISTRY FORMS COMMITTEE TO RESTRUCTURE PSU'S
TO TALK TO PM ON IRON ORE EXPORTS
CRUDE FALLS BELOW $60/BBL FOR THE 1ST TIME SINCE MAY ON ECONOMIC JITTERS
CIC ISSUED AN ORDER AGAINST SEBI IN THE MATTER ON JUN 26, 2009
BHOJ RAJ SAHU ASKED FOR LIST OF SHAREHOLDERS OF ALL DELISTED COS
CIC ORDER FAVOURING BHOJ RAJ SAHU ASKED FOR DATA ON DELISTED COS
CHALLENGES CENTRAL INFORMATION COMMISSION'S ORDER ON RTI
CRUDE FALLS BELOW $60/BBL ON THURSDAY ON ECONOMIC JITTERS
SEEKS RS.9000/TN CUT IN STEEL PRICES IN FY'10: NW
SENIOR MGMT CHANGES TO HELP IN POSITIONING THE COMPANY IN FUTURE
TO LAUNCH 100CC DISCOVER, POSITIONING AS A 'LONG DISTANCE BIKE'
TO LAUNCH 100CC DISCOVER, POSITIONING AS A 'LONG DISTANCE BIKE'
DISCOVER 100CC NOT TO REPLACE PLATINA 100, NOT AN ENTRY LEVEL BIKE
TO LAUNCH 100CC DISCOVER, POSITIONING 100 CC BIKE AS A 'LONG DISTANCE BIKE'
SEBI WANTS MIN 26% FREE FLOAT, FM TO GIVE TIME FOR IMPLEMENTATION: SRCS
APPOINTS INVST BANKS FOR FUND RAISING EXERCISE, PLANS TO RAISE $400MN: SRCS
FUND RAISING LARGELY TO REDUCE DEBT TO RS.7000 - 8000 CR
SUZLON PLANS TO RAISE $400MN: SOURCES
SUZLON APPOINTS INVESTMENT BANKS FOR FUND RAISING EXERCISE: SOURCES
LEAD BANKERS INCLUDE CREDIT SUISSE, CITI & DEUTSCHE BANK: SOURCES
SUZLON TO RAISE FUNDS VIA GDR OR QIP ROUTE: SOURCES
NEED TO REVAMP SAT WILL BE REVIEWED IN THE MEETING: SOURCES

Updated: 04/08/2008 | 06:34 PM IST

Top Stories

Press Trust of India

Monday, August 04, 2008 (Mumbai)

Blog

Comments:

Read (0)

Post

Rate the story

Orchid Chemicals and Pharmaceuticals on Monday said it has received European Union regulatory approval for marketing Piperacillin and Tazobactam injection, used in the treatment of bacterial infection.

The Chennai-based generic pharma firm filed the marketing authorisation for this product with the UK Medicines and Healthcare products Regulatory Agency to enable the company to launch the product across EU countries, Orchid Chemicals said in a filing to Bombay Stock Exchange.

Piperacillin and Tazobactam for injection is used in the treatment or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

"Through this approval, we are expanding into a new product range of premium Penicillin Injectables and also foraying into EU generic market," Orchid Chemicals and Pharmaceuticals Managing Director K Raghavendra Rao said.

The company is launching the injection in the European Union through its exclusive marketing alliance with Hospira, Rao added.

Shares of the company closed at Rs 259.60, up 3.67 per cent on the BSE on Monday.